Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04435977
Title Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma (Immunocabo)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Istituto Clinico Humanitas
Indications

hepatocellular carcinoma

Therapies

Cabozantinib

Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.